Professor Yaochun Shen PhD
Professor Electrical Engineering and Electronics
- +44 (0)151 794 4575
- Work email Y.C.Shen@liverpool.ac.uk
Research
Research Overview
Advanced 3D imaging technology
• Terahertz imaging and compressed sensing
• Optical coherence tomography (OCT)
Applications in healthcare, pharmaceutical, automotive and energy
• Medical diagnosis and tissue dynamics
• Non-destructive & quantitative evaluation/testing
• In-situ process monitoring
• High-speed ultrahigh-resolution OCT for the diagnosis of eye diseases and systemic disorders
If you are interested, please contact me (e-mail: ycshen@liverpool.ac.uk; mobile: 07954391635; WeChat: ycshen888) to discuss opportunities around.
Useful links:
➢ How to apply for PhD study at Liverpool: https://www.liverpool.ac.uk/study/postgraduate-research/how-to-apply/
➢ PhD scholarships and awards: https://www.liverpool.ac.uk/study/postgraduate-research/fees-and-funding/scholarships-and-awards/
➢ For Chinese Applicants: https://www.liverpool.ac.uk/study/postgraduate-research/fees-and-funding/scholarships-and-awards/the-university-of-liverpool-and-china-scholarship-council-awards/
Ultrahigh resolution OCT for corneal imaging
The LiveOCT device is based on our patented line-field illumination technology. It achieves high imaging speed of over 200,000 A-scans per second and an ultra-high axial resolution of 2 microns that is higher than typical axial resolution of existing OCT systems (5 -10 microns).
Our LiveOCT device meets all the regulatory standards and is currently being used for clinical studies at the Royal Liverpool Hospital.
This project is funded by NIHR via i4i scheme (II-LA-0813-20005, 2015—2017) and (II-LA-1116-20008, 2017—2022).
New Low-Cost Point of Care Imaging Technologies for Diabetic Eye Disease in China
Diabetic retinopathy (DR) is an eye disease that can cause vision loss and blindness in people who have diabetes. Treatments are effective but only if the disease is detected early enough. Current methods of detecting DR rely on costly imaging equipment and many skilled personnel to take and interpret retinal images. We have developed novel, low-cost, diagnostic technologies for the detection of DR. These technologies will enable cost-effective, large-scale detection of sight-threatening disease to be performed by non-expert health care workers at the time and place of patient care in China and worldwide.
This project is funded by EPSRC Global Challenges Research Fund (EP/R014094/1, 2018—2022).
The group will also develop a low-cost handheld OCT to make this technology accessible in sub-Saharan Africa, as part of a large project funded by the UK Wellcome Trust (222530/Z/21/Z, 2022—2026).
Development of an innovative imaging solution for screening of Diabetic Peripheral Neuropathy
Diabetic peripheral neuropathy (DPN) is nerve damage caused by diabetes and can lead to numbness, loss of sensation, nerve-related pain in the feet, legs, and hands. Screening of DPN will improve care by enabling early intervention where DPN is more readily reversible. At present, there is no effective screening programme for DPN due to a lack of sensitive, scalable population-based tests.
In this project we will develop the first kind of integrated intelligent imaging solution tailored to the needs of DPN screening. Early detection and timely treatment of DPN by our innovations will prevent disability and save lives with substantial benefit to the UK's society and economy.
This project is funded by EPSRC (EP/X01441X/1, 08/2023--07/2027)
Research Grants
Closed Loop Digitalised Data Analytics and Analysis Platform (DAAP) for Intelligent Design and Manufacturing of Next Generation Power Semiconductor Modules
ENGINEERING & PHYSICAL SCIENCES RESEARCH COUNCIL
April 2022 - September 2024
Predicting Acute and Post-Recovery Outcomes in Cerebral Malaria by Optical Coherence Tomography
WELLCOME TRUST (UK)
April 2022 - March 2026
High temperature heat resistant silicone gel and its effect on the reliability of high temperature SiC power module
DEPARTMENT FOR BUSINESS, ENERGY AND INDUSTRIAL STRATEGY (BEIS) (UK)
December 2018 - June 2023
Quantitative Detection of Trace Biomarkers using Graphene-integrated Tunable Metamaterials based Attenuated Total Reflection Terahertz Spectroscopy
ROYAL SOCIETY (CHARITABLE)
March 2019 - March 2022
Market Research for Commercialisation of a Next Generation OCT Device
QUEEN'S UNIVERSITY BELFAST (UK)
August 2018 - October 2018
GCRF/Newton Consolidation Award
ENGINEERING & PHYSICAL SCIENCES RESEARCH COUNCIL
February 2018 - March 2023
Clinical Development of an Ultrasensitive OCT Device to Improve the Management of Eye Disease
DEPARTMENT OF HEALTH & SOCIAL CARE (UK)
November 2017 - July 2022
Impact Acceleration Account - University of Liverpool 2012
ENGINEERING & PHYSICAL SCIENCES RESEARCH COUNCIL
October 2012 - March 2017
Ultrasensitive OCT Imaging for Eye Disease
DEPARTMENT OF HEALTH & SOCIAL CARE (UK)
February 2015 - January 2019
Towards disease diagnosis through spectrochemical imaging of tissue architecture.
ENGINEERING & PHYSICAL SCIENCES RESEARCH COUNCIL
June 2013 - September 2016
Intelligent Manufacturing of Pharmaceutical Film Coating Using Terahertz Pulsed Imaging, Optical Coherence Tomography and Numerical Modelling
ENGINEERING & PHYSICAL SCIENCES RESEARCH COUNCIL
June 2014 - October 2016
Small items of Research Equipment at the University of Liverpool
ENGINEERING & PHYSICAL SCIENCES RESEARCH COUNCIL
November 2012 - March 2013
Real-time in-situ monitoring and control technique for high value pharmaceutical manufacturing
INNOVATE UK (UK)
July 2008 - June 2010
Advanced terahertz sources and imaging configurations for rapid analytical measurement applications
ROYAL SOCIETY (CHARITABLE)
September 2008 - October 2008